Neuralstem to Present at 29th Annual ROTH Conference – P&T Community

Posted: Published on March 8th, 2017

This post was added by Dr Simmons

Neuralstem to Present at 29th Annual ROTH Conference
P&T Community
Neuralstem's stem cell therapy product candidate, NSI-566, is a spinal cord-derived neural stem cell line. Neuralstem is currently evaluating NSI-566 in three indications: stroke, chronic spinal cord injury (cSCI), and Amyotrophic Lateral Sclerosis (ALS).

and more »

Read the original:
Neuralstem to Present at 29th Annual ROTH Conference - P&T Community

Related Posts
This entry was posted in Spinal Cord Injury Treatment. Bookmark the permalink.

Comments are closed.